The University of Chicago Header Logo

Connection

David Grdina to Animals

This is a "connection" page, showing publications David Grdina has written about Animals.
Connection Strength

0.889
  1. Altered expression of a metformin-mediated radiation response in SA-NH and FSa tumor cells treated under in vitro and in vivo growth conditions. Int J Radiat Biol. 2017 07; 93(7):665-675.
    View in: PubMed
    Score: 0.038
  2. Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivity. Free Radic Biol Med. 2016 10; 99:110-119.
    View in: PubMed
    Score: 0.036
  3. NF?B and Survivin-Mediated Radio-Adaptive Response. Radiat Res. 2015 Apr; 183(4):391-7.
    View in: PubMed
    Score: 0.033
  4. Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs. Radiat Res. 2014 May; 181(5):464-70.
    View in: PubMed
    Score: 0.031
  5. A survivin-associated adaptive response in radiation therapy. Cancer Res. 2013 Jul 15; 73(14):4418-28.
    View in: PubMed
    Score: 0.029
  6. A manganese superoxide dismutase (SOD2)-mediated adaptive response. Radiat Res. 2013 Feb; 179(2):115-24.
    View in: PubMed
    Score: 0.028
  7. SOD2-mediated adaptive responses induced by low-dose ionizing radiation via TNF signaling and amifostine. Free Radic Biol Med. 2011 Nov 15; 51(10):1918-25.
    View in: PubMed
    Score: 0.026
  8. Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response. Int J Radiat Oncol Biol Phys. 2009 Mar 01; 73(3):886-96.
    View in: PubMed
    Score: 0.022
  9. Maintenance of manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by repeated administration of the free thiol form of amifostine. Radiat Res. 2008 May; 169(5):495-505.
    View in: PubMed
    Score: 0.021
  10. Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs. Radiat Res. 2004 Nov; 162(5):536-46.
    View in: PubMed
    Score: 0.016
  11. Antimetastatic effectiveness of amifostine therapy following surgical removal of Sa-NH tumors in mice. Semin Oncol. 2002 Dec; 29(6 Suppl 19):22-8.
    View in: PubMed
    Score: 0.014
  12. Delayed cytoprotection after enhancement of Sod2 (MnSOD) gene expression in SA-NH mouse sarcoma cells exposed to WR-1065, the active metabolite of amifostine. Radiat Res. 2002 Jul; 158(1):101-9.
    View in: PubMed
    Score: 0.014
  13. Relationships between cytoprotection and mutation prevention by WR-1065. Mil Med. 2002 Feb; 167(2 Suppl):51-3.
    View in: PubMed
    Score: 0.013
  14. Inhibition of spontaneous metastases formation by amifostine. Int J Cancer. 2002 Jan 10; 97(2):135-41.
    View in: PubMed
    Score: 0.013
  15. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nat Commun. 2020 09 14; 11(1):4591.
    View in: PubMed
    Score: 0.012
  16. Further evidence that the radioprotective aminothiol, WR-1065, catalytically inactivates mammalian topoisomerase II. Cancer Res. 2000 Mar 01; 60(5):1186-8.
    View in: PubMed
    Score: 0.012
  17. Amifostine: mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol Drug Interact. 2000; 16(4):237-79.
    View in: PubMed
    Score: 0.012
  18. Chemopreventive doses of amifostine confer no cytoprotection to tumor nodules growing in the lungs of mice treated with cyclophosphamide. Semin Oncol. 1999 Apr; 26(2 Suppl 7):22-7.
    View in: PubMed
    Score: 0.011
  19. Effects of thiols on topoisomerase-II alpha activity and cell cycle progression. Cell Prolif. 1998 Oct-Dec; 31(5-6):217-29.
    View in: PubMed
    Score: 0.011
  20. Repression of c-myc gene expression by the thiol and disulfide forms of the cytoprotector amifostine. Carcinogenesis. 1997 Dec; 18(12):2457-9.
    View in: PubMed
    Score: 0.010
  21. WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II alpha leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells. Cell Prolif. 1997 Jun-Jul; 30(6-7):283-94.
    View in: PubMed
    Score: 0.010
  22. Andrographis paniculata Diterpenoids Protect against Radiation-Induced Transformation in BALB/3T3 Cells. Radiat Res. 2017 07; 188(1):66-74.
    View in: PubMed
    Score: 0.010
  23. The inhibition of radiation-induced mutagenesis by the combined effects of selenium and the aminothiol WR-1065. Mutat Res. 1996 Sep 23; 356(2):147-54.
    View in: PubMed
    Score: 0.009
  24. Antimutagenic effects of amifostine: clinical implications. Semin Oncol. 1996 Aug; 23(4 Suppl 8):53-7.
    View in: PubMed
    Score: 0.009
  25. The Increase in Animal Mortality Risk following Exposure to Sparsely Ionizing Radiation Is Not Linear Quadratic with Dose. PLoS One. 2015; 10(12):e0140989.
    View in: PubMed
    Score: 0.009
  26. Expression of thymidine kinase messenger RNA and a related transcript is modulated by radioprotector WR1065. Cancer Res. 1995 Nov 01; 55(21):4788-92.
    View in: PubMed
    Score: 0.009
  27. The effects of cycloheximide and WR-1065 on radiation-induced repair processes: a mechanism for chemoprevention. Carcinogenesis. 1995 Nov; 16(11):2699-705.
    View in: PubMed
    Score: 0.009
  28. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action. Carcinogenesis. 1995 Apr; 16(4):767-74.
    View in: PubMed
    Score: 0.008
  29. CDK4-mediated MnSOD activation and mitochondrial homeostasis in radioadaptive protection. Free Radic Biol Med. 2015 Apr; 81:77-87.
    View in: PubMed
    Score: 0.008
  30. Varying levels of radioprotection from the effects of JANUS neutrons in repair-deficient xrs-5 hamster cells treated with azacytidine. Radiat Res. 1994 Dec; 140(3):437-40.
    View in: PubMed
    Score: 0.008
  31. Chromosome terminal deletion formation in Chinese hamster ovary cells. Mutat Res. 1994 Nov 01; 311(1):125-31.
    View in: PubMed
    Score: 0.008
  32. Protection against radiation-induced mutagenesis at the hprt locus by spermine and N,N"-(dithiodi-2,1-ethanediyl)bis-1,3-propanediamine (WR-33278). Mutagenesis. 1994 Jul; 9(4):355-60.
    View in: PubMed
    Score: 0.008
  33. Inhibition of topoisomerase II alpha activity in CHO K1 cells by 2-[(aminopropyl)amino]ethanethiol (WR-1065). Radiat Res. 1994 Apr; 138(1):44-52.
    View in: PubMed
    Score: 0.008
  34. Protection from radiation-induced apoptosis by the radioprotector amifostine (WR-2721) is radiation dose dependent. Cell Biol Toxicol. 2014 Feb; 30(1):55-66.
    View in: PubMed
    Score: 0.008
  35. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet. 2013 Dec; 45(12):1439-45.
    View in: PubMed
    Score: 0.008
  36. Induction of hprt mutations in mice after exposure to fission-spectrum neutrons or 60Co gamma rays. Radiat Res. 1993 Nov; 136(2):289-92.
    View in: PubMed
    Score: 0.008
  37. Comparing radiation toxicities across species: an examination of radiation effects in Mus musculus and Peromyscus leucopus. Int J Radiat Biol. 2013 Jun; 89(6):391-400.
    View in: PubMed
    Score: 0.007
  38. The effects of radiation and dose-fractionation on cancer and non-tumor disease development. Int J Environ Res Public Health. 2012 Dec 18; 9(12):4688-703.
    View in: PubMed
    Score: 0.007
  39. CyclinB1/Cdk1 phosphorylates mitochondrial antioxidant MnSOD in cell adaptive response to radiation stress. J Mol Cell Biol. 2013 Jun; 5(3):166-75.
    View in: PubMed
    Score: 0.007
  40. The radioprotector WR-2721 reduces neutron-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in mouse splenocytes when administered prior to or following irradiation. Carcinogenesis. 1992 May; 13(5):811-4.
    View in: PubMed
    Score: 0.007
  41. In vivo protection by the aminothiol WR-2721 against neutron-induced carcinogenesis. Int J Radiat Biol. 1992 May; 61(5):567-76.
    View in: PubMed
    Score: 0.007
  42. Antimutagenic effects of radioprotector WR-2721 against fission-spectrum neurons and 60Co gamma-rays in mice. Int J Radiat Biol. 1992 Mar; 61(3):387-92.
    View in: PubMed
    Score: 0.007
  43. Reversion of radiosensitivity in azacytidine-treated XRS5 cells does not result in full radioprotection by WR-1065. Int J Radiat Oncol Biol Phys. 1992; 23(5):999-1002.
    View in: PubMed
    Score: 0.007
  44. Chemical protection and cell-cycle effects on radiation-induced mutagenesis. Cell Prolif. 1992 Jan; 25(1):23-9.
    View in: PubMed
    Score: 0.007
  45. Protection by WR-2721 and WR-151327 against late effects of gamma rays and neutrons. Adv Space Res. 1992; 12(2-3):257-63.
    View in: PubMed
    Score: 0.007
  46. Induction of cellular antioxidant defense by amifostine improves ventilator-induced lung injury. Crit Care Med. 2011 Dec; 39(12):2711-21.
    View in: PubMed
    Score: 0.007
  47. Misoprostol, a PGE1 analog, protects mice from fission-neutron injury. Radiat Res. 1991 Oct; 128(1 Suppl):S12-7.
    View in: PubMed
    Score: 0.007
  48. Protection by WR-151327 against late-effect damage from fission-spectrum neutrons. Radiat Res. 1991 Oct; 128(1 Suppl):S124-7.
    View in: PubMed
    Score: 0.007
  49. Protection against late effects of radiation by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 1991 Aug 15; 51(16):4125-30.
    View in: PubMed
    Score: 0.006
  50. The effect of chemical radiation protectors on cell cycle progression after gamma or neutron irradiation. Cell Prolif. 1991 May; 24(3):271-80.
    View in: PubMed
    Score: 0.006
  51. Association of WR-1065 with CHO AA8 cells, nuclei, and nucleoids. Radiat Res. 1991 Feb; 125(2):152-7.
    View in: PubMed
    Score: 0.006
  52. Pathological effects of the radiation protector WR-151327 in mice. Radiat Res. 1990 Oct; 124(1):79-84.
    View in: PubMed
    Score: 0.006
  53. Amifostine metabolite WR-1065 disrupts homologous recombination in mammalian cells. Radiat Res. 2010 Feb; 173(2):175-83.
    View in: PubMed
    Score: 0.006
  54. Plasminogen activator activity in clonogenic cell populations separated from a murine fibrosarcoma. Clin Exp Metastasis. 1989 Mar-Apr; 7(2):243-50.
    View in: PubMed
    Score: 0.005
  55. Protection by WR1065 and WR151326 against fission-neutron-induced mutations at the HGPRT locus in V79 cells. Radiat Res. 1989 Mar; 117(3):500-10.
    View in: PubMed
    Score: 0.005
  56. Protection against radiation-induced mutagenesis in V79 cells by 2-[(aminopropyl)amino] ethanethiol under conditions of acute hypoxia. Radiat Res. 1989 Feb; 117(2):251-8.
    View in: PubMed
    Score: 0.005
  57. Radiation protectors: the unexpected benefits. Drug Metab Rev. 1989; 20(1):13-42.
    View in: PubMed
    Score: 0.005
  58. The effect of 2-[(aminopropyl)amino] ethanethiol on fission-neutron-induced DNA damage and repair. Br J Cancer. 1989 Jan; 59(1):17-21.
    View in: PubMed
    Score: 0.005
  59. Amifostine reduces lung vascular permeability via suppression of inflammatory signalling. Eur Respir J. 2009 Mar; 33(3):612-24.
    View in: PubMed
    Score: 0.005
  60. Differential protection of radiation-induced DNA single-strand breaks and cell survival by solcoseryl. Experientia. 1988 Aug 15; 44(8):707-8.
    View in: PubMed
    Score: 0.005
  61. Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine. Int J Radiat Biol. 2008 Aug; 84(8):623-34.
    View in: PubMed
    Score: 0.005
  62. Cell cycle redistribution of cultured cells after treatment with chemical radiation protectors. Cell Tissue Kinet. 1988 May; 21(3):193-200.
    View in: PubMed
    Score: 0.005
  63. Radioprotectors in treatment therapy to reduce risk in secondary tumor induction. Pharmacol Ther. 1988; 39(1-3):21-5.
    View in: PubMed
    Score: 0.005
  64. 2-[(Aminopropyl)amino] ethanethiol-mediated reductions in 60Co gamma-ray and fission-spectrum neutron-induced chromosome damage in V79 cells. Radiat Res. 1988 Jan; 113(1):145-54.
    View in: PubMed
    Score: 0.005
  65. Modification of radiation response in mice by fractionated extracts of Panax ginseng. Radiat Res. 1987 Oct; 112(1):156-63.
    View in: PubMed
    Score: 0.005
  66. Radiation-induced DNA single-strand breaks in the intestinal mucosal cells of mice treated with the radioprotectors WR-2721 or 16-16 dimethyl prostaglandin E2. Int J Radiat Biol Relat Stud Phys Chem Med. 1987 Jul; 52(1):67-76.
    View in: PubMed
    Score: 0.005
  67. The effect of 2-[(aminopropyl)amino] ethanethiol (WR-1065) on radiation induced DNA double strand damage and repair in V79 cells. Br J Cancer. 1987 May; 55(5):477-82.
    View in: PubMed
    Score: 0.005
  68. The effect of 2-[(aminopropyl)amino] ethanethiol (WR1065) on radiation-induced DNA damage and repair and cell progression in V79 cells. Br J Cancer. 1986 Dec; 54(6):933-41.
    View in: PubMed
    Score: 0.005
  69. Protective effects of 2-[(aminopropyl)amino] ethanethiol against bleomycin and nitrogen mustard-induced mutagenicity in V79 cells. Int J Radiat Oncol Biol Phys. 1986 Aug; 12(8):1475-8.
    View in: PubMed
    Score: 0.005
  70. 2-[(Aminopropyl)amino]ethanethiol (WR1065) is anti-neoplastic and anti-mutagenic when given during 60Co gamma-ray irradiation. Carcinogenesis. 1986 Apr; 7(4):665-8.
    View in: PubMed
    Score: 0.004
  71. Protection against cis-diamminedichloroplatinum cytotoxicity and mutagenicity in V79 cells by 2-[(aminopropyl)amino]ethanethiol. Cancer Res. 1986 Mar; 46(3):1132-5.
    View in: PubMed
    Score: 0.004
  72. Protective effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid against induction of altered hepatocyte foci in rats treated once with gamma-radiation within one day after birth. Cancer Res. 1985 Nov; 45(11 Pt 1):5379-81.
    View in: PubMed
    Score: 0.004
  73. The radioprotector WR1065 reduces radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in V79 cells. Carcinogenesis. 1985 Jun; 6(6):929-31.
    View in: PubMed
    Score: 0.004
  74. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat Res. 2004 Dec; 162(6):711-28.
    View in: PubMed
    Score: 0.004
  75. Effectiveness of AMSA alone or in combination with radiation on murine fibrosarcoma pulmonary nodules. Clin Exp Metastasis. 1984 Jul-Sep; 2(3):223-33.
    View in: PubMed
    Score: 0.004
  76. Cell synchrony techniques. I. A comparison of methods. Cell Tissue Kinet. 1984 May; 17(3):223-36.
    View in: PubMed
    Score: 0.004
  77. Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range. Int J Radiat Oncol Biol Phys. 1984 Mar; 10(3):379-83.
    View in: PubMed
    Score: 0.004
  78. Density gradient centrifugation of tumor cells from needle biopsies and their respective source tumors: a comparison of density distributions. Experientia. 1983 Aug 15; 39(8):916-7.
    View in: PubMed
    Score: 0.004
  79. Cytotoxic effects of vincristine on tumour subpopulations separated from pulmonary nodules. Br J Cancer. 1983 Aug; 48(2):279-87.
    View in: PubMed
    Score: 0.004
  80. Oral administration is as effective as intraperitoneal administration of amifostine in decreasing nitroxide EPR signal decay in vivo. Biochim Biophys Acta. 2003 Mar 20; 1637(2):151-5.
    View in: PubMed
    Score: 0.004
  81. Treatment of artificially-induced pulmonary metastases with fractionated doses of vincristine and/or radiation therapy. Clin Exp Metastasis. 1983 Jan-Mar; 1(1):71-81.
    View in: PubMed
    Score: 0.004
  82. Lung tumorigenic response of strain A mice exposed to hypoxic cell sensitizers alone and in combination with gamma-radiation. Cancer Res. 1983 Jan; 43(1):146-9.
    View in: PubMed
    Score: 0.004
  83. Kinetic heterogeneity in density-separated murine fibrosarcoma subpopulations. Cancer Res. 1982 Dec; 42(12):4999-5003.
    View in: PubMed
    Score: 0.004
  84. Cyclic-radiation response of murine fibrosarcoma cells grown as pulmonary nodules. Int J Radiat Oncol Biol Phys. 1982 Oct; 8(10):1727-34.
    View in: PubMed
    Score: 0.003
  85. Phase-specific cytotoxicity in vivo of hydroxyurea on murine fibrosarcoma pulmonary nodules. Br J Cancer. 1982 Mar; 45(3):438-46.
    View in: PubMed
    Score: 0.003
  86. Method of RNA purification from endothelial cells for DNA array experiments. Biotechniques. 2002 Feb; 32(2):316, 318, 320.
    View in: PubMed
    Score: 0.003
  87. Density centrifugation of murine fibrosarcoma cells following in situ labelling with tritiated thymidine. Cell Tissue Kinet. 1981 Nov; 14(6):589-600.
    View in: PubMed
    Score: 0.003
  88. In vivo cell cycle phase-preferential killing of murine fibrosarcoma cells by cisplatin. Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):845-51.
    View in: PubMed
    Score: 0.003
  89. Velocity sedimentation of tumor cells: a comparison of methods. Experientia. 1981 May 15; 37(5):501-2.
    View in: PubMed
    Score: 0.003
  90. Radiosensitivity of mammalian cell lines engineered to overexpress cytosolic glutathione peroxidase. Radiat Res. 2001 Apr; 155(4):536-42.
    View in: PubMed
    Score: 0.003
  91. Cytotoxic effect in vivo of selected chemotherapeutic agents on synchronized murine fibrosarcoma cells. Br J Cancer. 1980 Nov; 42(5):677-83.
    View in: PubMed
    Score: 0.003
  92. Separation of solid tumor cell populations. Antibiot Chemother (1971). 1980; 28:137-41.
    View in: PubMed
    Score: 0.003
  93. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations. Cancer Clin Trials. 1980; 3(2):149-54.
    View in: PubMed
    Score: 0.003
  94. Diminished aqueous microviscosity of tumors in murine models measured with in vivo radiofrequency electron paramagnetic resonance. Cancer Res. 1999 Nov 15; 59(22):5836-41.
    View in: PubMed
    Score: 0.003
  95. Cytotoxic effect of adriamycin in vivo on synchronized murine fibrosarcoma cells. Int J Radiat Oncol Biol Phys. 1979 Aug; 5(8):1305-8.
    View in: PubMed
    Score: 0.003
  96. Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity. Cancer Res. 1999 Jul 01; 59(13):3059-63.
    View in: PubMed
    Score: 0.003
  97. Phase-specific cytotoxicity in vivo of hydroxyurea on murine fibrosarcoma cells synchronized by centrifugal elutriation. Br J Cancer. 1979 Feb; 39(2):152-8.
    View in: PubMed
    Score: 0.003
  98. Separation of cells from a murine fibrosarcoma on the basis of size. I. Relationship between cell size and age as modified by growth in vivo or in vitro. J Natl Cancer Inst. 1978 Jul; 61(1):209-14.
    View in: PubMed
    Score: 0.003
  99. Separation of cells from a murine fibrosarcoma on the basis of size. II. Differential effects of cell size and age on lung retention and colony formation in normal and preconditioned mice. J Natl Cancer Inst. 1978 Jul; 61(1):215-20.
    View in: PubMed
    Score: 0.003
  100. Response of selected tumour cell populations separated from a fibrosarcoma following irradiation in situ with fast neutrons. Br J Radiol. 1978 Apr; 51(604):291-301.
    View in: PubMed
    Score: 0.003
  101. Relevance of density, size and DNA content of tumour cells to the lung colony assay. Br J Cancer. 1977 Dec; 36(6):659-69.
    View in: PubMed
    Score: 0.003
  102. Regulation of thymus PCNA expression is altered in radiation-sensitive wasted mice. Carcinogenesis. 1996 Nov; 17(11):2357-65.
    View in: PubMed
    Score: 0.002
  103. Radiation response of cell populations irradiated in situ and separated from a fibrosarcoma. Radiat Res. 1976 Jun; 66(3):634-43.
    View in: PubMed
    Score: 0.002
  104. Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry. Radiat Res. 1996 May; 145(5):610-8.
    View in: PubMed
    Score: 0.002
  105. Separation of clonogenic cells from stationary phase cultures and a murine fibrosarcoma by density-gradient centrifugation. Methods Cell Biol. 1976; 14:213-28.
    View in: PubMed
    Score: 0.002
  106. UV-induced changes in cell cycle and gene expression within rabbit lens epithelial cells. Photochem Photobiol. 1996 Jan; 63(1):79-85.
    View in: PubMed
    Score: 0.002
  107. Radiation response of clonogenic cell populations separated from fibrosarcoma. Radiat Res. 1975 Sep; 63(3):483-93.
    View in: PubMed
    Score: 0.002
  108. Oxymetry deep in tissues with low-frequency electron paramagnetic resonance. Proc Natl Acad Sci U S A. 1994 Dec 20; 91(26):13047-51.
    View in: PubMed
    Score: 0.002
  109. Transformation of human epidermal keratinocytes with fission neutrons. Carcinogenesis. 1994 Dec; 15(12):2867-73.
    View in: PubMed
    Score: 0.002
  110. Radioprotection by WR-151327 against the late normal tissue damage in mouse hind legs from gamma ray radiation. Int J Radiat Oncol Biol Phys. 1994 Nov 15; 30(4):867-72.
    View in: PubMed
    Score: 0.002
  111. Separation of clonogenic cells from stationary phase cultures by density gradient centrifugation. Exp Cell Res. 1974 Mar 30; 85(1):15-22.
    View in: PubMed
    Score: 0.002
  112. Separation of cells from a fibrosarcoma in renografin density gradients. J Natl Cancer Inst. 1974 Jan; 52(1):253-7.
    View in: PubMed
    Score: 0.002
  113. Buoyant density separation of human blood cells in renografin gradients. Exp Cell Res. 1973 Sep; 81(1):250-4.
    View in: PubMed
    Score: 0.002
  114. Effects of growth media on cell cycle progression in CHO cells exposed to the radioprotector WR-1065. Cell Prolif. 1992 Nov; 25(6):643-50.
    View in: PubMed
    Score: 0.002
  115. Accumulation of CHO cells in G2 phase following exposure to WR-1065. Radiat Res. 1991 May; 126(2):223-8.
    View in: PubMed
    Score: 0.002
  116. Analysis of free radical damage within single cells using flow cytometry. Mol Aspects Med. 1991; 12(2):129-35.
    View in: PubMed
    Score: 0.002
  117. Cellular radiosensitivity in V79 cells is linked to alterations in chromatin structure. Int J Radiat Oncol Biol Phys. 1990 Nov; 19(5):1199-201.
    View in: PubMed
    Score: 0.002
  118. The increase in radioresistance of Chinese hamster cells cultured as spheroids is correlated to changes in nuclear morphology. Radiat Res. 1990 Feb; 121(2):175-9.
    View in: PubMed
    Score: 0.001
  119. Conformational changes in chromatin structure induced by the radioprotective aminothiol, WR 1065. Br J Cancer. 1989 Dec; 60(6):893-6.
    View in: PubMed
    Score: 0.001
  120. Characterization of a human ovarian carcinoma. Anal Quant Cytol Histol. 1989 Oct; 11(5):324-30.
    View in: PubMed
    Score: 0.001
  121. The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma. Am J Obstet Gynecol. 1989 Apr; 160(4):789-97.
    View in: PubMed
    Score: 0.001
  122. The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy. Gynecol Oncol. 1989 Feb; 32(2):236-9.
    View in: PubMed
    Score: 0.001
  123. Halogenated pyrimidines as radiosensitizers for high-LET radiation. Radiat Res. 1989 Feb; 117(2):351-5.
    View in: PubMed
    Score: 0.001
  124. Effects of separate and combined treatments with gamma radiation and diethylnitrosamine in neonatal rats on the induction of altered hepatocyte foci and hepatic tumors. Carcinogenesis. 1987 Apr; 8(4):599-600.
    View in: PubMed
    Score: 0.001
  125. A comparison of radioprotection from three neutron sources and 60Co by WR-2721 and WR-151327. Radiat Res. 1986 May; 106(2):224-33.
    View in: PubMed
    Score: 0.001
  126. Synergistic induction of altered hepatocyte foci by combined gamma radiation and diethylnitrosamine administered to neonatal rats. Carcinogenesis. 1986 Mar; 7(3):445-8.
    View in: PubMed
    Score: 0.001
  127. Cell synchrony techniques. II. Analysis of cell progression data. Cell Tissue Kinet. 1984 May; 17(3):237-45.
    View in: PubMed
    Score: 0.001
  128. Response of fibrosarcoma cell subpopulations to small doses of radiation delivered in situ. Int J Radiat Oncol Biol Phys. 1983 Feb; 9(2):217-20.
    View in: PubMed
    Score: 0.001
  129. Radiation sensitivity of murine fibrosarcoma cells separated by centrifugal elutriation. Radiat Res. 1979 Nov; 80(2):389-97.
    View in: PubMed
    Score: 0.001
  130. Density gradient centrifugation of cells separated from multicellular tumor spheroids. Experientia. 1979 Jun 15; 35(6):815-7.
    View in: PubMed
    Score: 0.001
  131. Separation of cells from mouse solid tumors by centrifugal elutriation. Cancer Res. 1977 Dec; 37(12):4291-6.
    View in: PubMed
    Score: 0.001
  132. Cell cycle dependency of metastatic lung colony formation. Cancer Res. 1977 Oct; 37(10):3690-3.
    View in: PubMed
    Score: 0.001
  133. In vitro destruction of tumor cells by macrophages from mice treated with Corynebacterium granulosum. J Natl Cancer Inst. 1975 Sep; 55(3):589-96.
    View in: PubMed
    Score: 0.001
  134. Nonspecific Immunotherapy of Murine Solid Tumors With Corynebacterium granulosum. J Natl Cancer Inst. 1975 Apr; 54(4):895-902.
    View in: PubMed
    Score: 0.001
  135. Destruction of hamster ovarian cell cultures by peritoneal macrophages from mice treated with Corynebacterium granulosum. J Natl Cancer Inst. 1974 Jun; 52(6):1839-42.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.